Lauren Périères, Camelia Protopopescu, Gora Lo, Fabienne Marcellin, El Hadji Ba, Marion Coste, Coumba Touré Kane, Aldiouma Diallo, Cheikh Sokhna, Sylvie Boyer, Grp Anrs 12356 Ambass Survey Study, Cyril Bérenger, Marwân-Al-Qays Bousmah, Patrizia Carrieri, Maëlle de Sèze, Tchadine Djaogol, Gwenaëlle Maradan, Carole Treibich, El Hadji Ba Ba, Fambaye Dièye, Assane Diouf, Elhadji Bilal Faye, Assane Ndiaye, Mouhamadou Baba Sow, Anna Julienne Selbé Ndiaye, Samba Ndiour, Philippe Halfon, Sofiane Mohamed, Nicolas Rouveau, Maria‐camila Calvo Cortès, Gabrièle Laborde‐balen, Martine Audibert, Fatou Fall, Ibrahima Gueye, Karine Lacombe, Moussa Seydi, Yusuke Shimakawa, Edouard Tuaillon, Muriel Vray, Journal of Viral Hepatitis, Vol. 28, No. 11, pp. 1515-1525, 11/2021
Abstract
Sub-Saharan Africa's hepatitis B virus (HBV) burden is primarily due to infection in infancy. However, data on chronic HBV infection prevalence and associated risk factors in children born post-HBV vaccination introduction are scarce. We estimated hepatitis B surface antigen (HBsAg) prevalence and risk factors in Senegalese children born during the HBV vaccination era. In 2018-2019, a community-based cross-sectional survey was conducted in Senegal among children born between 2004 and 2015 (ie after the three-dose HBV vaccine series was introduced (2004) but before the birth dose's introduction (2016)). HBsAg-positive children were identified using dried blood spots. A standardized questionnaire collected socioeconomic information. Data were age-sex weighted and calibrated to be representative of children living in the study area. Risk factors associated with HBsAg positivity were identified using negative binomial regression. Among 1,327 children, 17 were HBsAg-positive (prevalence = 1.23% (95% confidence interval [CI] 0.61-1.85)). Older age (adjusted incidence-rate ratio [aIRR] 1.31 per one-year increase, 95% CI 1.10-1.57), home vs healthcare facility delivery (aIRR 3.55, 95% CI 1.39-9.02), stitches (lifetime) (aIRR 4.79; 95% CI 1.84-12.39), tattoos (aIRR 8.97, 95% CI 1.01-79.11) and having an HBsAg-positive sibling with the same mother (aIRR 3.05, 95% CI 1.09-8.57) were all independently associated with HBsAg positivity. The low HBsAg prevalence highlights the success of the Senegalese HBV vaccination program. To further reduce HBV acquisition in children, high-risk groups, including pregnant women and siblings of HBsAg-positive individuals, must be screened. Vital HBV infection prevention measures include promoting delivery in healthcare facilities, and increasing awareness of prevention and control procedures.
Keywords
Child, Hepatitis B, Prevalence, Risk factors, Senegal